Treg adoptive therapy: Is more better?

Blood

Volumn 127, Issue 8, 2016, Pages 962-963

  Parmar, Simrit ^a   Shpall, Elizabeth J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD64 ANTIGEN; CD86 ANTIGEN; CYCLOPHOSPHAMIDE; FLUDARABINE; PROTEIN KINASE C; RAPAMYCIN; RETINOIC ACID; STAT1 PROTEIN; STAT5 PROTEIN;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTING CELL; EFFECTOR CELL; FUCOSYLATION; GOOD MANUFACTURING PRACTICE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE HOMING; PRIORITY JOURNAL; RECURRENCE RISK; REGULATORY T LYMPHOCYTE; REVIEW; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION; ADVERSE EFFECTS; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; IMMUNOTHERAPY; MALE; PROCEDURES; TRANSPLANTATION;

CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOTHERAPY; MALE; T-LYMPHOCYTES, REGULATORY;

EID: 84960390391     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2015-12-682492     Document Type: Review

References (10)

1. Brunstein CG, Miller JS, McKenna DH, et al. Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect. Blood. 2016;127(8):1044-1051.
2. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood. 2011;117(3):1061-1070.
3. Zanin-Zhorov A, Ding Y, Kumari S, et al. Protein kinase C-theta mediates negative feedback on regulatory T cell function. Science. 2010;328(5976):372-376.
4. Vogtenhuber C, Bucher C, Highfill SL, et al. Constitutively active Stat5b in CD41 T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses. Blood. 2010;116(3):466-474.
5. + T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice. J Clin Invest. 2011; 121(7):2554-2569.
6. Lu L, Lan Q, Li Z, et al. Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci USA. 2014;111(33):E3432-E3440.
7. Singh K, Stempora L, Harvey RD, et al. Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. Am J Transplant. 2014;14(12):2691-2703.
8. Parmar S, Liu X, Najjar A, et al. Ex vivo fucosylation of third-party human regulatory T cells enhances antigraft-versus-host disease potency in vivo. Blood. 2015; 125(9):1502-1506.
9. Di Ianni M, Falzetti F, Carotti A, et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood. 2011;117(14): 3921-3928.
10. Martelli MF, Di Ianni M, Ruggeri L, et al. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. Blood. 2014;124(4):638-644.